AzTrials
AzTrials

ExerciseNCT05294133

Implementation of a 12-week Adapted Physical Activity (APA) Program in People Suffering From Chronic Insomnia.

A study testing physical activity in people with Exercise and Health Behavior, run by Universite du Littoral Cote d'Opale at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

One third of men and women are not satisfied with their sleep. A non-drug countermeasure to improve sleep in insomniacs could be adapted physical activity (APA). However, research is needed because the literature is limited and the few studies are most often based on subjective data with a great methodological… Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Exercise, Health Behavior, Sleep
What is being tested?
physical activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteFrance
Study dates
1 Sep 2021to 1 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Men and women aged 18 to 60 with chronic insomnia (according to the 5 criteria of the Diagnostic and Statistical Manual) without any other associated sleep pathology (sleep apnea, restless legs syndrome, etc.)

Who cannot join

  • Medical contraindication to physical activity Associated serious medical pathologies (cancer...) Night work, jet lag during the last month, young children BMI> 30 Current use or <3 months of psychoactive, hypnotic, stimulant or analgesic medications Alcohol or drug abuse

Trial locations and contacts

1 site in 1 country.

Pauline BARON, Phd Student contact

0673681126

pauline_baron@orange.fr

France1 site, 1 recruiting
  • University of littoral cote d'ople

    Dunkirk

    Pauline BARON, phd student, 0673681125, pauline_baron@orange.fr

    Recruiting

Other trials in France

About this study

One third of men and women are not satisfied with their sleep. A non-drug countermeasure to improve sleep in insomniacs could be adapted physical activity (APA). However, research is needed because the literature is limited and the few studies are most often based on subjective data with a great methodological disparity. Within the framework of the care pathway of Dr ARON's patients, sleep doctor at the Sommeil Morphée Center of the Grande Synthe Polyclinic (59), the objective of this project is to make an APA program more reliable in order to improve sleep, to understand the underlying mechanisms and to include APA in the therapeutic management.

Read the detailed description

According to the 2019 National Sleep and Vigilance Institute survey, in France, one-third of men and women are not satisfied with their sleep, and nearly half struggle to fall asleep or return to sleep. Given the growing evidence of the harmful effects of lack of sleep, its alteration on health, these figures are alarming.

Insomnia is characterized by dissatisfaction with the quantity or quality of sleep, difficulty initiating and/or maintaining sleep, and early morning awakenings at least three times a week for a minimum period of three months.

In a Sleep Medicine Reviews report, it was shown that many patients diagnosed with insomnia had a physiological hyperarousal disorder that resulted in poor sleep, which has been found in insomniacs in numerous studies. It is observed in particular on the autonomic nervous system by a low variability of heart rate and a high level of noradrenaline reflecting a dominant sympathetic axis. An anxiogenic and depressive profile and elevated cortisol levels are also often associated with this hyperarousal encountered in insomniacs. In addition, an alteration of the circadian rhythm seems to favor insomnia. Indeed, a decrease in core temperature and cortisol levels in the evening are primary mechanisms for sleep onset. A study showed an elevated sleep latency in individuals with this delayed circadian temperature rhythm. In the same study, a high wake-up time after sleep was associated with a high core temperature. Regarding cortisol, a smaller decline in cortisol and higher cortisol levels at the end of the day are associated with shorter sleep duration, lower sleep efficiency, and poor subjective sleep quality.

Although a first treatment of insomnia would be to find a good lifestyle and optimal sleep conditions, the majority of first-line remedies in the treatment of insomnia remain pharmacological today, through the short- or medium-term prescription of hypnotics, neuroleptics, anxiolytic benzodiazepines or some antidepressants.

If the practice of regular physical activity is now well known to improve overall health, what about sleep?

In 2017, the investigators published a study showing that an adapted Physical Activity (PA) program improved sleep in a population of young women. Overall, studies regarding the effects of exercise and physical activity are still recent but increasingly confirm the beneficial effects of PA on sleep.

Indeed, the literature reveals that there is an inverse correlation between the amount of PA and the severity of sleep disturbance.

In fact, it appears that regular physical activity decreases the recurrence of insomnia. In adults over 40 years of age with sleep disorders, a 10- to 16-week training program very significantly improved the qualitý of sleep and shortened sleep latency.

According to these same authors, PA thus poses as a reliable alternative to pharmacological management by showing a positive effect of PA on sleep.

However, further work is needed because the literature remains limited and sometimes contradictory. Moreover, the studies are most often based on subjective data with a great methodological disparity. The type of physical activity proposed in these different studies is very variable, ranging from aerobic exercise to muscle strengthening to yoga or other relaxation activities. To the best of our knowledge, there is no consensus on the intensity of exercise to be preferred to improve sleep.

1.1 Objectives

The objective of this project is therefore to evaluate the effects of an APA program in insomnia treatment therapies.

The follow-up of physiological and medical markers, throughout the APA program, will make it possible to observe the effect of the DK pulse intervention, to determine the mechanisms underlying the improvement of sleep by physical activity and thus to propose an optimization of the programs dedicated to the improvement of sleep.

The aim will be to extend this program from the local basin to the regional level (or even beyond) and to use the network of local APA structures to make this management as easy as possible for the patients.

1.1 General assumptions

The investigators hypothesize that the 12-week physical activity program will improve objective and subjective sleep in patients with insomnia. This improvement in sleep will be explained in part by a decrease in capillary cortisol levels, an increase in heart rate variability, a decrease in stress and/or an increase in circadian rhythm amplitude throughout the PA program.

This study is the second of three studies of the thesis of Pauline Baron (ULCO PhD student, financed by the Haut de France Region, in collaboration with health care services (Dr Aron).

The treating physicians of patients suffering from insomnia direct their patients to the dedicated sleep consultations for clinical assessment.

The sleep specialists propose physical activity within the framework of a prescription, after diagnostic and etiological assessments, and evaluation of the patients' symptoms, the comorbidities are evaluated in the same way as the motivation of the participants, and they ask the patients grouping the various criteria of inclusion/exclusion of the study if they wish to participate in a scientific study.

After the patient's informed consent, they are referred to Pauline BARON.

During the inclusion visit, the investigator reminds them in detail of the objectives and the course of the protocol. An information leaflet is given to each participant, who signs an authorization to participate in the study, accepting in particular the randomization of the groups (AP or control). The control group will not receive any intervention.

Adapted Physical Activities are programmed within the DK Pulse association, one of the 138 structures labelled Maison du Sport Santé (https://www.sports.gouv.fr/accueil-du-site/actualites/article/les-premieres-maisons-sport-sante-sont-desormais-connues ). The physical activity program is a 12-week program with 1 hour of aerobic type physical activity, of moderate intensity, 3 times a week (duration, frequency and intensity presumed to date according to the state of the art). The intensity of the physical activity (between 60 and 80% of VO2max) will be controlled by an RPE scale and a heart rate monitor.

The physical activity of the patients will be financially supported by the university.

As part of the care pathway, the investigators will evaluate different variables.

The variables will be measured at T0, T6 and T12 weeks for the 2 groups.

The following anthropometric and physiological parameters are measured:

Height (Tanita Leicester HR001 electronic height gauge); Body mass and composition (Tanita DC-360) Resting blood pressure (non-dominant arm, sitting position, Omron M3); White blood cell count measurement by capillary measurement (HemoCue® WBC DIFF Analyzer). Lack of sleep negatively affects the immune system. It is therefore interesting, especially in this health context, to measure the white blood cell count in patients suffering from insomnia, in order to prevent a possible infection.

Hair sampling for cortisol measurement (only at T0 and T12). The measurement of hair cortisol is essential in the care of a patient suffering from insomnia. It reflects the activity of the hypothalamic-pituitary-adrenal axis (HPA). An abnormally high level of cortisol and a disturbance of this axis can be a triggering or aggravating factor of insomnia.

Cardiorespiratory capacity on an ergometer (Monark e939): YMCA incremental submaximal test, up to 85% of the theoretical HR max, allowing to evaluate by projection the Maximum Aerobic Power (MAP) and the associated maximal O2 consumption (VO2max).

The evaluation is completed by taking an "e-celsius bodycap" capsule. This capsule allows continuous monitoring of the patient's core temperature. It is naturally eliminated in the stool. The follow-up of the central temperature is essential in the course of care of an insomniac patient. Indeed, it is one of the reflections of the biological clock and therefore allows us to observe the circadian rhythm and its amplitude.

At the end of this visit, patients will leave with :

an accelerometer, a Dreem research 2 headband a sleep diary and a physical activity log, a heart rate monitor (Polar H10).

During the following week, the participants equipped with the accelerometer on their wrist (non-dominant arm), fill out a daily sleep diary: wake-up and bedtime, naps.

They sleep with an EEG headband (Dreem 2 Research) that provides data for estimating the different stages of sleep.

The accelerometer allows to measure some sleep parameters such as total sleep time and time of nocturnal awakenings, the amount of physical activity and the associated energy expenditure (Actilife 6 software) during the 7 days. A PA diary will also be completed daily (type, intensity, duration).

Participants will wear the heart rate belt for 3 nights (from bedtime to sunrise) to record RR intervals (precise duration between each heartbeat) from which heart rate variability will be extracted (over a minimum interval of 5 hours). The frequency analysis of the RR signal allows to evaluate the respective activations of the sympathetic and parasympathetic nervous systems.

Each device is pre-programmed, no additional manipulation is necessary.

At the end of the 7 days, the participants return the equipment and answer several questionnaires:

On sleep and sleepiness: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI) and EPWORTH sleepiness scale On stress and quality of life: Perceived Stress Scale (PSS) and the Short Form Health Study (SF 36) On PA level: International Fitness Scale (IFIS)

Being tested
physical activity
Medical subject headings
Motor Activity, Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05294133
Study groupRoleWhat they receive
control groupNo interventionno intervention
physical activityExperimentalNot described
Receives: Behavioral: physical activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. subjective sleep change

    questionnaire insomnia severity index. The minimum score is 0 and the maximum is 28. Higher scores mean a worse outcome. A score higher than 14 is considered as a person with clinical insomnia.

    Measured: before and after the 12 weeks

  2. objective sleep change

    Participants were fitted with an accelerometer on their wrist (non-dominant arm) for 7 days to assess the quantity and quality of their sleep

    Measured: before and after the 12 weeks

Secondary outcomes (5)
  1. circadian rythm change

    continuous temperature with BodyCap capsules

    Measured: before and after the 12 weeks

  2. objective stress change

    cortisol level in hair

    Measured: before and after the 12 weeks

  3. hearth rate variability change

    Measured: before and after the 12 weeks

  4. physical capacity change

    Young Men's Christian Association (YMCA) submaximal VO2 test

    Measured: before and after the 12 weeks

  5. subjective stress change

    Perceived Stress Scale- 10. The minimum score is 10 and the maximum is 50. Higher scores mean a worse outcome. A score higher than 27 is considered as a person with very high perceived stress level.

    Measured: before and after the 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2022
  2. Study start1 Sep 2021
  3. Primary completion1 Jan 2023 (estimated)
  4. Study completion1 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05294133
Sponsor's protocol ID
2021-A00862-39
Status last verified
Mar 2022
First submitted
10 Dec 2021
Last updated
5 Apr 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing physical activity in people with Exercise and Health Behavior, run by Universite du Littoral Cote d'Opale at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pauline BARON, Phd Student (0673681126, pauline_baron@orange.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

subjective sleep change (time frame: before and after the 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in